(Submitted for publication February 11, 1960 ; accepted June 11, 1960) During the last 40 years extensive investigations have been reported on various aspects of the metabolism of cardiac glycosides. A detailed review describing the cellular basis of cardiac glycoside action has been reported by Hajdu and Leonard (1) . One prime difficulty encountered in determining the metabolic fate of cardiac glycosides is in establishing a reliable and sensitive method for determining tissue, blood and urine levels of the glycosides as well as their derivatives in jian and in experimental animals. The minute amounts present in blood, urine and tissues after oral or parenteral administration require extremely sensitive assay methods. Digitalis glycosides have been studied by utilizing bioassay (2-9), colorimetric (10) (11) (12) (13) (14) , radioisotopic (15) (16) (17) , and polarographic techniques (18, 19) .
The behavior and fate of digitoxin in experimental animals and in man have been reviewed by Friedman, St. George and Bine (20) . In Friedman's laboratory, bioassay techniques using embryonic duck hearts have detected 0.1 K.g of digitoxin per ml of serum of humans who received 1.2 mg digitoxin intravenously (21) . The method consists of the observation of cardiac irregularities in embryonic duck hearts immersed in test fluids (8, 22) . This group has reported reproducible results in studies of experimental animals and humans (8, 20, (22) (23) (24) (25) (26) (27) (28) (29) (30) .
Digitoxin labeled with carbon14 has been shown to be an excellent tool for appraising the behavior and fate of the glycoside (15) (16) (17) (31) (32) (33) (34) (35) (36) (37) (38) (39, 40) . The physiology and toxicology of tritium in man were studied extensively by Pinson and Langham (41) .
This report presents preliminary data from studies in dogs using digoxin-H3 administered intravenously. were inserted and standard extremity electrocardiographic leads were recorded. Polyethylene catheters were introduced into the urinary bladder with 13 gage hypodermic needles or through a cystostomy wound. The right chest cavity was entered at the fourth intercostal space. The pericardium was incised and sutured to the chest wall. A purse string suture was placed on the right auricular appendage and a polyethylene catheter was guided into the coronary sinus. A transfixing suture was used to sustain the catheter in the coronary sinus with careful avoidance of blockage to the coronary sinus. The patency of the various catheters was maintained by a constant flow of heparinized saline. The arterial catheters were washed at repeated intervals with heparinized saline. Digoxin-H', and digoxin injection (Lanoxin) were mixed with 0.9 per cent saline in a syringe in the amounts specified in Table I . The tritiumlabeled digoxin was made available in ampules containing 1 mg of digoxin labeled with 134 /Ac of tritium. The suspension was administered intravenously over one minute.
In order to make simultaneous collections, the serial collections from each blood vessel were made by three observers. Unless otherwise specified, samples were collected at 1, 3, 5, 10, 15, 30, 45 and 60 minutes after drug administration. Biopsy specimens were obtained from the right atrium and ventricle at predetermined intervals. Double mattress sutures were placed at the surgical site. At the termination of each experiment the animal was sacrificed. The liver, kidneys and heart were removed, weighed, and representative samples obtained. Total urine specimens were collected at various time intervals for measurement. The amount of fluid administered intravenously was determined for each study. Throughout the experiments, intra-arterial pressures and electrocardiograms were monitored and recorded.
Preparation of samples for determination of radioactivity 1. Blood. Ten ml of 95 per cent ethanol was added to 1 ml of heparinized blood in order to precipitate the protein. This was then centrifuged for 10 minutes at 2,500 rpm. Two ml of the clear supernate was removed and evaporated to dryness. The residue was dissolved in 0.4 ml of 95 per cent ethanol. Two-tenths ml was mixed with 15.0 ml of a solution made by mixing 0.01 g bisphenyloxazolylbenzene (a wavelength shifter), 0.20 g 2,5 diphenyloxazole (a phosphor), and 100.0 ml toluene. The samples were transferred to special counting vials and cooled in a freezer at 00 C for at least 24 hours. All samples were counted in a Packard Tri-Carb liquid scintillation spectrometer with a two-channel pulse-height analyzer. This instrument was calibrated daily, utilizing a standard containing 134 m,c of tritium-labeled digoxin. All samples were counted for 1 hour. Unless otherwise specified, counts were expressed in millimicrocuries per gram of tissue. Recovery experiments were performed by adding digoxin-H3 to blood and extracting as indicated. Approximately 95 to 98 per cent of the added radioactivity was recovered by the procedure used.
2. Urine. The urine samples were diluted with 95 per cent ethanol to a final dilution of 1: 2. Two ml was evaporated to dryness and the residue treated as described above.
3. Tissues. The tissue samples were dried with filter paper to remove blood and extracellular fluid. They were weighed, and preserved in 5.0 ml of 95 per cent ethanol until homogenized. Two ml of the homogenate was removed, evaporated to dryness, and treated as described above.
Chromatographic studies
Chromatographic studies were performed, using multiple solvent systems (see below) to identify the glycoside or its metabolites in urine and blood. These studies were necessary, since the concentration of radioactive material in blood and urine does not necessarily indicate the presence of unaltered digoxin H3. Control chromatographic observations were performed using alcoholic solutions of radioactive and nonradioactive digoxin, and mixtures of these solutions with blood and urine in multiple proportions (42) . Urine samples were precipitated with 40 per cent lead acetate and the supernate was extracted three times with chloroform (3 parts chloroform to 1 part urine). The chloroform extract was evaporated to dryness, and the residue dissolved in a 1: 1 chloroform: methanol solution. This final suspension was evaporated to a small volume and examined with chromatographic techniques. Details of these techniques are given by Gisvold and Wright (43) .
Chromatographic studies of digoxin solutions were carried out utilizing the following solvent systems: 1) chloroform-benzene-formamide (44) ; 2) chloroformwater-methanol (44); 3) benzene-chloroform-butanol (45) 4) benzene-ethyl acetate-chloroform (46) ; 5) methyl-isobutylketone-isopropyl ether-formamide (43) .
Optimal results were obtained with a slight modification of system 5. The proportions by volume were: methylisobutylketone, 8; isopropyl ether, 2; butanol, 1; and formamide, q.s. to saturate.
The chromatographic strips were allowed to develop in a closed jar saturated with the solvent system described. They were then passed quickly through a solution of 2.5 per cent meta-dinitrobenzene in chloroform and sprayed with a solution of 5 per cent KOH in methanol. The strips were examined under white and ultraviolet light. The Rf values were calculated for each chromatogram. The spots were sectioned off the paper, eluted with isopropanol, and processed for radioactivity counting as described previously.
EXPERIMENTAL RESULTS
Blood levels of digoxin-H3. Blood samples aspirated simultaneously from the femoral artery, femoral vein and coronary sinus showed a rapid decrease in radioactivity during the first 15 minutes (Table II) .
Ur-ine levels of digoxin-H3. Significant levels of the radioactive isotope were measured in the urine samples collected within 30 minutes after the intravenous injection of tritium-labeled digoxin (Table III) . Tissue levels of digoxin-H3. Studies of the tissue levels of the isotope revealed significant amounts of radioactive digoxin in the liver, kidneys and heart. In tissue samples obtained at the end of the experiment, the highest concentration of radioactive digoxin per gram of tissue was found in the kidney. An average of 633.40 mptc was recovered per g of kidney. Studies of liver and heart revealed an average recovery of 128.48 and 72.35 mnuc per g of tissue, respectively (Table IV ). An average of 68.73 per cent of the total administered radioactive digoxin was recovered in the liver, heart and kidneys (Table V) . These three organs accounted for an average of 4.1 per cent of the dog's body weight. The chromatographic strips obtained by using radioactive samples were cut lengthwise and studied, utilizing a Chromatogram scanner (Baird Atomic) with rectilinear galvanometric recorder (Texas Instrument, Inc.). A representative "curve" is depicted in Figure 1 . The spots were later sectioned off the paper, eluted and processed for counting as described previously (42) . DISCUSSION A technique has been described which appears to be suitable for the appraisal of certain aspects of the metabolism of a cardiac glycoside in blood, urine and body tissues.
Forty minutes after the injection of tritium-labeled digoxin, approximately 68 per cent of the drug could be recovered from the heart, kidneys and liver. This percentage of recovery compares favorably with studies utilizing digitoxin-C14 (17, Both digoxin and lanatoside C have been found to be excreted principally as the unchanged glysoside (38) . A conjugate of digoxigenin has also been identified in rat urine after the administration of digoxin and lanatoside C (38, 47) , and in rat bile after the administration of digoxin (48) . Three separate bands have been obtained in chromatographic studies of rat urine after the administration of acetyldigitoxin (47) . The band closest to the starting line could not be separated from metabolite B, a conjugate of digoxigenin. After hydrolysis this product could not be separarated from digoxigenin. A second band which could not be separated from metabolite G, digoxin, was also hydrolyzed to digoxigenin. Further studies are being carried out in this laboratory to identify any metabolite that may be present in dog urine after the intravenous administration of radioactive digoxin. The nature of the radioactive material present in the kidney, heart and liver is being investigated in this laboratory. From the data presented, it is evident that measurable levels of radioactive digoxin can be determined in blood, urine, heart, kidneys and liver of dogs receiving 3 to 7 ,u of tritium per kg. According to published reports (49) "the maximal permissible amount of the radioisotope in the total body is 2 x 103 ,uc." Extrapolation of the data presented in this report suggests that satisfactory levels of the isotope should be obtained in humans using digoxin-H3 in dosages well within the permissible radioactivity. Preliminary observations regarded as satisfactory have been obtained in studies of urine and blood samples in one human (42) . Apparently, studies of the metabolic pathways of digoxin in humans over long periods of time may be performed without dangerous exposure to radiation (50) . SUM 
MARY
Blood, urine and body tissue levels of tritiumlabeled digoxin were studied in five mongrel dogs.
The isotopic concentrations were mieasured by the liquid scintillation technique. Utilizing chromatographic techniques, the radioactive material excreted in the urine after the intravenous administration of the drug could not be distinguished from unaltered digoxin.
